Mapping of the High-Risk Human Papillomavirus in Clients Received for Voluntary Cervical Cancer Screening in Five Health Regions of Burkina Faso

Objective: This paper aims to study the mapping of high-risk oncogenic Human Papilloma Virus in clients who received voluntary cervical cancer screening in five health regions of Burkina Faso. Patients and Methods: This was a multicenter and cross-sectional study with a descriptive aim which took place over a period of 25 months from July 1, 2021 to July 30, 2023. Results: Our study population consisted of 8512 clients who had taken the HPV DNA test in the health regions named Center, Center-West, Center-East, Plateau Central and Cascades in Burkina Faso. The average age of the clients was 38.03 ± 9.69 years. The overall prevalence of HR-HPV was 22.99%. The “Other HPV” serotypes were the most frequent in a proportion of 54.27%, followed by serotypes 16 and 18 respectively in 14.46% and 13.95% of cases. The prevalence of HR-HPV was 42.75% among HIV + clients. The serotypes of the “Other HPV” group (HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) were the most common among clients with a precancerous cervical lesion in 57.54% of cases. Conclusion: The health regions of Center, Center-East, Center-West, Plateau Central and Cascades in Burkina Faso have a high prevalence of HR-HPV. The “Other HPV” serotypes were the most dominant. A further study to identify by isolating the prevalence of the different serotypes of the “Other HPV” group in these five health regions of Burkina Faso is essential to be able to choose the most appropriate type of HPV vaccine.